https://www.selleckchem.com/products/arq-197.html
Secondary lymphedema is a chronic condition that may result from cancer-related treatments. Evidence is emerging on prospective surveillance and risk reduction. Databases were systematically searched through April 1, 2019, for comparative studies evaluating interventions aiming to prevent lymphedema in patients with cancer. A random-effects model was used to perform meta-analysis, when appropriate. A total of 26 studies (4,095 patients) were included, with 23 providing data sufficient for meta-analysis. Surveillance programs increased t
पसंद करना
टिप्पणी
शेयर करना
